Geron Corporation (GERN) - Latest Market Data

Price & Market Data

Price: $1.43

Daily Change: +$0.0093 / 0.65%

Range: $1.36 - $1.44

Market Cap: $904,416,448

Volume: 6,357,119

Performance Metrics

1 Week: 11.81%

1 Month: -16.47%

3 Months: -52.82%

6 Months: -64.59%

1 Year: -59.43%

YTD: -59.89%

Company Details

Employees: 229

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Selected stocks

Vertical Aerospace Ltd. (EVTL)

Mobilicom Limited (MOB)

TAT Technologies Ltd. (TATT)